Orthofix Medical (OFIX) to Release Earnings on Tuesday

Orthofix Medical (NASDAQ:OFIX) is expected to be issuing its Q1 2025 quarterly earnings data before the market opens on Tuesday, May 6th. Analysts expect the company to announce earnings of ($0.17) per share and revenue of $191.10 million for the quarter.

Orthofix Medical Trading Down 0.5 %

Shares of OFIX stock opened at $14.12 on Tuesday. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.39 and a quick ratio of 1.11. Orthofix Medical has a 1-year low of $12.08 and a 1-year high of $20.73. The business has a 50-day moving average of $15.67 and a 200 day moving average of $17.10. The stock has a market capitalization of $550.99 million, a PE ratio of -4.51 and a beta of 0.99.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. Roth Mkm restated a “buy” rating and set a $22.00 price objective on shares of Orthofix Medical in a research note on Wednesday, February 26th. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $24.00 price target on shares of Orthofix Medical in a report on Wednesday, February 26th. Finally, StockNews.com raised shares of Orthofix Medical from a “hold” rating to a “buy” rating in a research note on Tuesday, February 25th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $23.33.

Insider Transactions at Orthofix Medical

In other Orthofix Medical news, insider Jorge Andres Cedron sold 3,816 shares of the company’s stock in a transaction dated Wednesday, April 16th. The shares were sold at an average price of $13.31, for a total transaction of $50,790.96. Following the transaction, the insider now directly owns 42,500 shares in the company, valued at approximately $565,675. This represents a 8.24 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Lucas Vitale sold 4,287 shares of Orthofix Medical stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $16.60, for a total value of $71,164.20. Following the sale, the insider now owns 135,317 shares of the company’s stock, valued at approximately $2,246,262.20. This represents a 3.07 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 9,242 shares of company stock worth $141,710 over the last ninety days. Company insiders own 2.60% of the company’s stock.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.